Rudolf Uher
#131,187
Most Influential Person Now
Canadian researcher
Rudolf Uher's AcademicInfluence.com Rankings
Rudolf Uherpsychology Degrees
Psychology
#2846
World Rank
#3270
Historical Rank
Personality Psychology
#35
World Rank
#38
Historical Rank
Clinical Psychology
#239
World Rank
#243
Historical Rank
Download Badge
Psychology
Why Is Rudolf Uher Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rudolf Uher is a Canadian psychiatrist and professor in the Department of Psychiatry at Dalhousie University in Halifax, Nova Scotia, Canada. His research focuses on the causes, prevention, and treatment of severe mental illnesses such as psychosis, major depression, and bipolar disorder. He was a Canada Research Chair in Early Intervention in Psychiatry at Dalhousie University in 2012. He received the Max Hamilton Memorial Prize from the International College of Neuropsychopharmacology in 2014 and the Royal-Mach-Gaensslen Prize for Mental Health Research from the Royal Ottawa Mental Health Centre in 2016. In May 2020, he was chosen as one of two Nova Scotia experts, along with Emily Marshall, to receive grant funding from the Canadian Institutes of Health Research and Research Nova Scotia as part of a Rapid Research Funding Opportunity. Uher's funding will support his research on the mental health effects of the COVID-19 pandemic, which specifically focuses on parents with preexisting mental illnesses. In June 2020, a study he led reported that individuals with depression who did not respond to the commonly used serotonergic antidepressant escitalopram did respond to treatment with aripiprazole.
Rudolf Uher's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression (2018) (1816)
- Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. (2011) (1135)
- A mega-analysis of genome-wide association studies for major depressive disorder (2013) (979)
- Genetic Sensitivity to the Environment: The Case of the Serotonin Transporter Gene and Its Implications for Studying Complex Diseases and Traits (2010) (922)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (536)
- Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. (2010) (521)
- The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis (2008) (519)
- Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. (2013) (518)
- Rare and low-frequency coding variants alter human adult height (2016) (511)
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015) (508)
- Medial prefrontal cortex activity associated with symptom provocation in eating disorders. (2004) (434)
- The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update (2010) (425)
- Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. (2010) (330)
- Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors' and Longitudinal ‘Targets' (2012) (330)
- An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. (2014) (324)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (317)
- Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. (2009) (288)
- Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. (2013) (287)
- Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms (2011) (282)
- The contribution of prenatal and postnatal maternal anxiety and depression to child maladjustment (2011) (279)
- Measuring depression: comparison and integration of three scales in the GENDEP study (2007) (256)
- Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis (2013) (255)
- Genome-wide association study of major recurrent depression in the U.K. population. (2010) (251)
- MAJOR DEPRESSIVE DISORDER IN DSM‐5: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH OF CHANGES FROM DSM‐IV (2014) (251)
- Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis (2014) (248)
- Cerebral processing of food-related stimuli: Effects of fasting and gender (2006) (244)
- Functional Neuroanatomy of Body Shape Perception in Healthy and Eating-Disordered Women (2005) (236)
- Adverse reactions to antidepressants. (2009) (228)
- Gene–Environment Interactions in Severe Mental Illness (2014) (227)
- Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. (2013) (219)
- Recovery and chronicity in anorexia nervosa brain activity associated with differential outcomes (2003) (210)
- Genetic predictors of response to antidepressants in the GENDEP project (2009) (204)
- Differential Neural Responses to Food Images in Women with Bulimia versus Anorexia Nervosa (2011) (197)
- Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure underpinning obesity (2017) (193)
- The role of genetic variation in the causation of mental illness: an evolution-informed framework (2009) (188)
- Contribution of Common Genetic Variants to Antidepressant Response (2013) (184)
- Etiology in psychiatry: embracing the reality of poly‐gene‐environmental causation of mental illness (2017) (182)
- The Impact of Phenotypic and Genetic Heterogeneity on Results of Genome Wide Association Studies of Complex Diseases (2013) (181)
- SELF‐REPORT AND CLINICIAN‐RATED MEASURES OF DEPRESSION SEVERITY: CAN ONE REPLACE THE OTHER? (2012) (176)
- Polygenic interactions with environmental adversity in the aetiology of major depressive disorder (2015) (173)
- Repetitive Transcranial Magnetic Stimulation Reduces Cue-Induced Food Craving in Bulimic Disorders (2010) (170)
- An investigation of decision making in anorexia nervosa using the Iowa Gambling Task and skin conductance measurements (2007) (169)
- Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression (2009) (169)
- Effect of Left Prefrontal Repetitive Transcranial Magnetic Stimulation on Food Craving (2005) (167)
- Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression (2017) (166)
- Brain lesions and eating disorders (2005) (163)
- Minimal phenotyping yields genome-wide association signals of low specificity for major depression (2020) (154)
- Therapygenetics: The 5HTTLPR and response to psychological therapy (2011) (152)
- Relative impact of maternal depression and associated risk factors on offspring psychopathology (2012) (151)
- The implications of gene–environment interactions in depression: will cause inform cure? (2008) (149)
- Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. (2011) (148)
- Moderation of antidepressant response by the serotonin transporter gene (2009) (143)
- Combining clinical variables to optimize prediction of antidepressant treatment outcomes. (2016) (135)
- Classification of feeding and eating disorders: review of evidence and proposals for ICD‐11 (2012) (135)
- Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. (2010) (132)
- Differential motivational responses to food and pleasurable cues in anorexia and bulimia nervosa: a startle reflex paradigm (2006) (132)
- MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes (2017) (131)
- Neural correlates of body dissatisfaction in anorexia nervosa (2010) (127)
- Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis (2012) (120)
- Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. (2011) (120)
- Eating disorders, gene–environment interactions and epigenetics (2011) (116)
- Trajectories of change in depression severity during treatment with antidepressants (2009) (112)
- Insulin resistance and outcome in bipolar disorder. (2015) (109)
- Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: A genome-wide association and polygenic scoring study (2014) (108)
- Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients (2016) (106)
- Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis. (2015) (105)
- Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response (2013) (105)
- Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project (2010) (104)
- Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project (2009) (103)
- Genomewide Association Scan of Suicidal Thoughts and Behaviour in Major Depression (2011) (103)
- Association of Maternal Use of Folic Acid and Multivitamin Supplements in the Periods Before and During Pregnancy With the Risk of Autism Spectrum Disorder in Offspring (2018) (99)
- The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls (2018) (99)
- Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. (2011) (96)
- Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders (2015) (95)
- Time for united action on depression: a Lancet–World Psychiatric Association Commission (2022) (89)
- An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype (2017) (89)
- Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project (2011) (87)
- Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium (2017) (87)
- Depressive disorder moderates the effect of the FTO gene on body mass index (2012) (86)
- Elevated pain threshold in eating disorders: physiological and psychological factors. (2005) (86)
- An examination of decision making in bulimia nervosa (2009) (85)
- Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response (2012) (85)
- Thinking about Eating Food Activates Visual Cortex with Reduced Bilateral Cerebellar Activation in Females with Anorexia Nervosa: An fMRI Study (2012) (83)
- Genes, environment, and individual differences in responding to treatment for depression. (2011) (81)
- Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response (2013) (76)
- Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. (2010) (76)
- Brain Age in Early Stages of Bipolar Disorders or Schizophrenia (2019) (76)
- I’m not as slim as that girl: Neural bases of body shape self-comparison to media images (2007) (76)
- Personality pathology among individuals with a lifetime history of anorexia nervosa. (2006) (75)
- Genetic differences in cytochrome P450 enzymes and antidepressant treatment response (2014) (75)
- Gene–environment interactions in common mental disorders: an update and strategy for a genome-wide search (2013) (75)
- Body weight as a predictor of antidepressant efficacy in the GENDEP project. (2009) (75)
- Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank (2019) (72)
- Gene–environment interplay in the etiology of psychosis (2018) (71)
- CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP (2012) (70)
- Pharmacogenetics of antidepressant response: A polygenic approach (2016) (69)
- DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP (2013) (68)
- The genetics of affective disorder and suicide (2010) (66)
- Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes (2019) (66)
- A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness (2014) (65)
- Obesity, dyslipidemia and brain age in first-episode psychosis. (2018) (65)
- Insulin Resistance, Diabetes Mellitus, and Brain Structure in Bipolar Disorders (2014) (65)
- SEROTONIN TRANSPORTER LENGTH POLYMORPHISM, CHILDHOOD MALTREATMENT, AND CHRONIC DEPRESSION: A SPECIFIC GENE–ENVIRONMENT INTERACTION (2013) (64)
- Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’ (2013) (62)
- Basing psychiatric classification on scientific foundation: Problems and prospects (2012) (60)
- Self-, parent-report and interview measures of obsessive-compulsive disorder in children and adolescents. (2008) (58)
- A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder (2015) (57)
- Revision of ICD – status update on feeding and eating disorders (2013) (55)
- Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies (2018) (53)
- The truth about genetic variation in the serotonin transporter gene and response to stress and medication (2011) (52)
- Autism risk following antidepressant medication during pregnancy (2017) (52)
- Variation in GNB3 predicts response and adverse reactions to antidepressants (2011) (51)
- Genome Wide Association Analysis of Copy Number Variation in Recurrent Depressive Disorder (2011) (51)
- A genome-wide association study of a sustained pattern of antidepressant response. (2013) (51)
- The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder (2014) (50)
- Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. (2011) (50)
- Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals† (2017) (49)
- Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report. (2019) (49)
- Estimating the heritability of reporting stressful life events captured by common genetic variants (2012) (48)
- Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas (2021) (48)
- Prospective Association between Childhood Behavioral Inhibition and Anxiety: a Meta-Analysis (2020) (48)
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depressive disorder (2017) (47)
- Screening young people for obsessive-compulsive disorder (2007) (47)
- Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder. (2013) (46)
- Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial (2009) (46)
- The Everyday Feeling Questionnaire: the structure and validation of a measure of general psychological well-being and distress (2010) (46)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (45)
- Biomarkers predicting treatment outcome in depression: what is clinically significant? (2012) (44)
- Poor decision making in male patients with anorexia nervosa. (2012) (44)
- Changes in body weight during pharmacological treatment of depression. (2011) (43)
- Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables (2018) (43)
- Integrative mouse and human mRNA studies using WGCNA nominates novel candidate genes involved in the pathogenesis of major depressive disorder. (2013) (43)
- Treatment response classes in major depressive disorder identified by model-based clustering and validated by clinical prediction models (2019) (42)
- FUNCTIONAL POLYMORPHISM IN THE BRAIN‐DERIVED NEUROTROPHIC FACTOR GENE INTERACTS WITH STRESSFUL LIFE EVENTS BUT NOT CHILDHOOD MALTREATMENT IN THE ETIOLOGY OF DEPRESSION (2014) (42)
- Psychosis Polyrisk Score (PPS) for the Detection of Individuals At-Risk and the Prediction of Their Outcomes (2019) (42)
- Trends in hospital admissions for eating disorders in a country undergoing a socio-cultural transition, the Czech Republic 1981–2005 (2010) (41)
- Predictors of response and drop-out during intensive dialectical behavior therapy. (2010) (40)
- The inability to ignore: distractibility in women with restricting anorexia nervosa (2008) (39)
- Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder (2012) (38)
- New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation (2017) (38)
- Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP (2019) (37)
- Association of polygenic score for major depression with response to lithium in patients with bipolar disorder (2020) (37)
- Subliminal food images compromise superior working memory performance in women with restricting anorexia nervosa (2012) (37)
- Neurotrophic factors in depression in response to treatment. (2015) (37)
- The Effect of Parental Modeling on Child Pain Responses: The Role of Parent and Child Sex. (2017) (36)
- Brain responses to body image stimuli but not food are altered in women with bulimia nervosa (2013) (36)
- Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis (2016) (36)
- CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration (2021) (36)
- Brain age in bipolar disorders: Effects of lithium treatment (2019) (36)
- Protective Effect of CRHR 1 Gene Variants on the Development of Adult Depression Following Childhood Maltreatment Replication and Extension (2009) (36)
- Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts (2018) (36)
- Classification issues and challenges in child and adolescent psychopathology (2012) (36)
- Childhood maltreatment and comorbid anxiety in people with bipolar disorder. (2016) (36)
- Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the 5-HTTLPR (2011) (35)
- Convergent Animal and Human Evidence Suggests a Role of PPM1A Gene in Response to Antidepressants (2011) (35)
- Reactivity of affect and self-esteem during remission in bipolar affective disorder: an experimental investigation. (2011) (35)
- Antidepressants, social adversity and outcome of depression in general practice. (2010) (35)
- The role of loss and danger events in symptom exacerbation in bipolar disorder. (2012) (35)
- Cognitive Performance in First-Degree Relatives of Individuals With vs Without Major Depressive Disorder: A Meta-analysis (2019) (34)
- Interaction between the BDNF gene Val/66/Met polymorphism and morning cortisol levels as a predictor of depression in adult women (2012) (33)
- Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression (2020) (33)
- Dissecting the Genetic Heterogeneity of Depression Through Age at Onset (2012) (33)
- Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring (2017) (32)
- Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels (2013) (32)
- Offspring of parents with schizophrenia, bipolar disorder, and depression: a review of familial high-risk and molecular genetics studies. (2019) (32)
- Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. (2010) (31)
- Exploring the role of drug-metabolising enzymes in antidepressant side effects (2015) (31)
- Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression (2012) (30)
- Attention-deficit hyperactivity disorder and anxiety disorders as precursors of bipolar disorder onset in adulthood (2018) (29)
- Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data (2018) (29)
- Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples (2018) (29)
- Gene-environment interaction: overcoming methodological challenges. (2008) (28)
- A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping (2019) (28)
- Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression (2013) (28)
- Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples (2018) (27)
- Investigation of blood mRNA biomarkers for suicidality in an independent sample (2014) (26)
- Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder (2016) (26)
- Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression. (2012) (26)
- Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants (2019) (24)
- Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report (2020) (24)
- Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness (2016) (22)
- The interaction between child maltreatment, adult stressful life events and the 5-HTTLPR in major depression. (2013) (22)
- History of suicide attempts among patients with depression in the GENDEP project. (2010) (22)
- Familiality and SNP heritability of age at onset and episodicity in major depressive disorder (2015) (22)
- Neurodevelopmental and genetic determinants of exposure to adversity among youth at risk for mental illness. (2019) (22)
- Copy number variants and therapeutic response to antidepressant medication in major depressive disorder (2014) (21)
- Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders (2021) (21)
- ATP-binding cassette sub-family F member 1 (ABCF1) is identified as a putative therapeutic target of escitalopram in the inflammatory cytokine pathway (2013) (21)
- Increasing Cognitive Load Reduces Interference from Masked Appetitive and Aversive but Not Neutral Stimuli (2014) (20)
- Classical Human Leukocyte Antigen Alleles and C4 Haplotypes Are Not Significantly Associated With Depression (2020) (20)
- Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2017) (20)
- Long-term effects of depression treatment. (2016) (19)
- Transcriptomics and the mechanisms of antidepressant efficacy (2016) (19)
- Genome-wide Burden of Rare Short Deletions Is Enriched in Major Depressive Disorder in Four Cohorts (2019) (19)
- Identifying the Common Genetic Basis of Antidepressant Response (2021) (19)
- It would not have happened to me at home: qualitative exploration of sojourns abroad and eating disorders in young Czech women. (2008) (18)
- Typology of clinical course in bipolar disorder based on 18-month naturalistic follow-up (2012) (18)
- Functional neuroanatomy of body checking in people with anorexia nervosa. (2013) (18)
- Prevalence of attention‐deficit/hyperactivity disorder in people with mood disorders: A systematic review and meta‐analysis (2021) (18)
- Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank (2019) (18)
- Pharmacoproteomic investigation into antidepressant response in two mouse inbred strains (2012) (18)
- Genome‐wide association analysis accounting for environmental factors through propensity‐score matching: Application to stressful live events in major depressive disorder (2013) (18)
- Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report (2018) (18)
- Observed psychopathology in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia (2019) (18)
- Genome-wide association study of co-occurring anxiety in major depression (2013) (17)
- Genetic predictors of antidepressant side effects: A grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study (2014) (17)
- Genetic susceptibility for bipolar disorder and response to antidepressants in major depressive disorder (2014) (17)
- Forum: The case for gene-environment interactions in psychiatry. (2008) (17)
- Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas (2021) (17)
- Epigenetic traces of childhood maltreatment in peripheral blood: a new strategy to explore gene-environment interactions. (2014) (16)
- Hot and cold executive functions in youth with psychotic symptoms (2017) (16)
- Larger right inferior frontal gyrus volume and surface area in participants at genetic risk for bipolar disorders (2018) (16)
- Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP) (2018) (16)
- NEUROTICISM MEDIATES THE EFFECT OF P2RX7 ON OUTCOMES OF MOOD DISORDERS (2012) (16)
- Polygenic risk for circulating reproductive hormone levels and their influence on hippocampal volume and depression susceptibility (2019) (15)
- Stability of symptoms across major depressive episodes in bipolar disorder. (2009) (15)
- Genetic disposition to inflammation and response to antidepressants in major depressive disorder. (2018) (15)
- The ethics of ‘Trials within Cohorts’ (TwiCs): 2nd international symposium (2017) (14)
- Childhood maltreatment and the medical morbidity in bipolar disorder: a case–control study (2017) (14)
- Neuroanatomical Bases of Eating Disorders (2003) (14)
- The ethics of ‘Trials within Cohorts’ (TwiCs): 2nd international symposium (2017) (14)
- Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report (2019) (13)
- The genome‐wide expression effects of escitalopram and its relationship to neurogenesis, hippocampal volume, and antidepressant response (2017) (13)
- Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment. (2019) (12)
- Modulation of thermal pain perception by stress and sweet taste in women with bulimia nervosa. (2009) (12)
- Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response (2012) (12)
- Sleep in Offspring of Parents With Mood Disorders (2019) (12)
- Disruptive mood dysregulation disorder in offspring of parents with depression and bipolar disorder (2017) (12)
- Hallucinations during lamotrigine treatment of bipolar disorder. (2006) (12)
- Cognitive-behavioural interventions for prevention and treatment of anxiety in young children: A systematic review and meta-analysis. (2020) (12)
- Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder. (2012) (11)
- A Nationwide Cohort Study of Nonrandom Mating in Schizophrenia and Bipolar Disorder. (2021) (11)
- Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder (2020) (11)
- Antidepressant Response in Major Depressive Disorder: A Genome-wide Association Study (2020) (11)
- Assessment of Psychopathology: Is Asking Questions Good Enough? (2020) (11)
- Persistent Depressive Disorder, Dysthymia, and Chronic Depression: Update on Diagnosis, Treatment (2014) (11)
- Anxiety disorders and childhood maltreatment as predictors of outcome in bipolar disorder. (2018) (11)
- Genomics and the classification of mental illness: focus on broader categories (2013) (11)
- Hedonic tone and its mood and cognitive correlates in Parkinson's disease. (2013) (11)
- Childhood Maltreatment Predicts Unfavorable Course of Illness and Treatment Outcome in Depression (2012) (11)
- Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder (2019) (10)
- Affective lability in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia (2019) (10)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (10)
- Basic symptoms in offspring of parents with mood and psychotic disorders (2019) (10)
- Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study (2020) (10)
- Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? (2012) (10)
- The developmental brain age is associated with adversity, depression, and functional outcomes among adolescents. (2021) (9)
- Provocation of Symmetry/Ordering Symptoms in Anorexia nervosa: A Functional Neuroimaging Study (2014) (9)
- Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression (2016) (9)
- Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis (2021) (9)
- Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE) (2021) (8)
- The Changing Understanding of the Genetic and Environmental Causes of Mental Illness (2013) (8)
- Sex-Dependent Shared and Non-Shared Genetic Architecture Across Mood and Psychotic Disorders (2020) (8)
- Use of socioeconomic status in health research. (2006) (8)
- Psychotic symptoms are associated with lower cortical folding in youth at risk for mental illness (2020) (8)
- Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth. (2021) (8)
- Like father like daughter: sex-specific parent-of-origin effects in the transmission of liability for psychotic symptoms to offspring. (2018) (8)
- Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report. (2020) (8)
- Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data (2018) (7)
- The Genetics of Mental Illness: A Guide for Parents and Adoption Professionals (2010) (6)
- Why negative meta-analyses may be false? (2013) (6)
- Probing the genome to understand suicide. (2010) (6)
- Multimodal Deep Learning for Mental Disorders Prediction from Audio Speech Samples (2019) (6)
- Review of an innovative approach to practical trials: the ‘cohort multiple RCT’ design (2015) (6)
- Assessing 42 inflammatory markers in 321 control subjects and 887 major depressive disorder cases: BMI and other confounders and overall predictive ability for current depression (2018) (6)
- Estimating Severity of Depression From Acoustic Features and Embeddings of Natural Speech (2021) (6)
- Specific anxiety disorders and subsequent risk for bipolar disorder: a nationwide study (2016) (6)
- Clinical course predicts long-term outcomes in bipolar disorder (2018) (6)
- Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers. (2019) (5)
- Biomarkers of treatment outcome in schizophrenia: Defining a benchmark for clinical significance (2015) (5)
- Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder. (2019) (5)
- Reliability of multimodal MRI brain measures in youth at risk for mental illness (2020) (5)
- Person‐centered measurement‐based care for depression (2016) (5)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (4)
- Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report (2021) (4)
- Sex-Specific Transmission of Anxiety Disorders From Parents to Offspring (2022) (3)
- Attention-deficit/hyperactivity disorder and other neurodevelopmental disorders in offspring of parents with depression and bipolar disorder (2021) (3)
- Association of a brain methylation site with clinical outcomes in depression does not replicate across populations. (2015) (3)
- SU38 A STUDY OF 42 INFLAMMATORY MARKERS IN 321 CONTROL SUBJECTS AND 887 MAJOR DEPRESSIVE DISORDER CASES: THE ROLE OF BMI AND OTHER CONFOUNDERS, AND THE PREDICTION OF CURRENT DEPRESSIVE EPISODE BY MACHINE LEARNING (2019) (3)
- Perception of food and emotional stimuli in anorexia nervosa (2001) (3)
- A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank (2020) (3)
- Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram (2021) (3)
- Faculty Opinions recommendation of Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. (2009) (3)
- Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study (2022) (2)
- Decision-making and ‘gut feeling’ in males with anorexia nervosa (2013) (2)
- Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response (2021) (2)
- Cognition in offspring of parents with psychotic and non-psychotic severe mental illness. (2020) (2)
- Significance of Speaker Embeddings and Temporal Context for Depression Detection (2021) (2)
- Youth Experience Tracker Instrument: A self‐report measure of developmental antecedents to severe mental illness (2020) (2)
- T38GENETIC COUNSELLING FOR THE PREVENTION OF MENTAL HEALTH CONSEQUENCES OF CANNABIS USE: A RANDOMIZED CONTROLLED TRIAL (2019) (2)
- Sine-Wave Speech and Privacy-Preserving Depression Detection (2021) (2)
- The neuroanatomical basis of eating disorders (2002) (2)
- Correction: Provocation of Symmetry/Ordering Symptoms in Anorexia nervosa: A Functional Neuroimaging Study (2014) (2)
- Visual memory in offspring of parents with mental illness (2020) (2)
- On Combining Global and Localized Self-Supervised Models of Speech (2022) (2)
- Genetic variation in the Major Histocompatibility Complex and association with depression (2018) (2)
- Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents. (2023) (2)
- F1000Prime recommendation of Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. (2009) (2)
- Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1 (2021) (1)
- Hair Cortisol in Twins: Heritability and Genetic Overlap with Psychological Variables and Stress-System Genes (2017) (1)
- Retraction (2014) (1)
- factors on offspring psychopathology Relative impact of maternal depression and associated risk (2012) (1)
- Genomics and the classification of mental illness: focus on broader categories (2013) (1)
- Adversity, Parental Mental Illness, and Risk of Depression in Youth (2017) (1)
- P.1.011 Identifying transcriptomic biomarkers for response to escitalopram in the inflammatory cytokine pathway (2012) (1)
- Metabolic variables associated with response to cognitive behavioural therapy for depression in females: A Canadian biomarker integration network for depression (CAN-BIND) study. (2021) (1)
- Visual memory and psychotic symptoms in youth (2020) (1)
- No Association Between Antidepressant Efficacy and rs28365143 in Corticotropin-Releasing Hormone Binding Protein in a Large Meta-Analysis. (2018) (1)
- F84. ASSOCIATIONS BETWEEN INTELLIGENCE, VERBAL WORKING MEMORY AND PROCESSING SPEED IN PARENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER AND THEIR 7-YEAR OLD OFFSPRING (2018) (1)
- “One Degree of Separation”: A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19 (2022) (1)
- Correction: Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank (2020) (1)
- Response to Kunte et al. (2015) (1)
- Managing patients’ information in a community mental health team (2006) (1)
- P382. Replication of Personalized Relapse Prediction in Patients With Major Depressive Disorder Using Digital Biomarkers (2022) (1)
- Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report. (2022) (1)
- The Text4HealthyAging Program: An Evidence-Based Text Messaging Innovation to Support Healthy Urban Aging in Canada and Australia (2022) (1)
- Parental Overprotection and Sleep Problems in Young Children (2021) (1)
- The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report. (2023) (1)
- Genetic counselling for the prevention of mental health consequences of cannabis use: A randomized controlled trial‐within‐cohort (2020) (1)
- Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response (2012) (1)
- Applications of Speech Analysis in Psychiatry (2023) (1)
- Minimal phenotyping yields genome-wide association signals of low specificity for major depression (2020) (1)
- Pharmacogenetics of antidepressant response: A polygenic approach. Progress in Neuro-Psychopharmacology and (2016) (1)
- Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: Is one better than the other? (2013) (1)
- Psychological interventions in offspring of parents with bipolar disorder (2018) (1)
- Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk (2021) (1)
- INTERGENERATIONAL TRANSMISSION OF PSYCHOPATHOLOGY AND EARLY IDENTIFICATION OF RISK: NEW INSIGHTS FROM THE STUDY OF CHILD AND ADOLESCENT OFFSPRING OF PARENTS LIVING WITH DEPRESSION, BIPOLAR DISORDER, AND SCHIZOPHRENIA (2020) (0)
- General discussion (1980) (0)
- 48 META-ANALYSIS OF CYP2C19 ASSOCIATION WITH EFFICACY AND SIDE EFFECTS OF CITALOPRAM AND ESCITALOPRAM USING DATA FROM GENOME-WIDE ASSOCIATION STUDIES (2019) (0)
- women morning cortisol levels as a predictor of depression in adult gene Val / 66 / Met polymorphism and BDNF Interaction between the (2012) (0)
- M56. ASSORTATIVE MATING IN SCHIZOPHRENIA AND BIPOLAR DISORDER: A NATIONWIDE COHORT STUDY EXPLORING THE CHARACTERISTICS OF INDIVIDUALS WHO HAVE CHILDREN BY PARTNERS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER (2020) (0)
- M31 IMPACT OF CYP2C19 AND CYP2D6 GENE VARIANTS ON PLASMA LEVELS AND TREATMENT RESPONSE IN PATIENTS RECEIVING ESCITALOPRAM AND ARIPIPRAZOLE FOR MAJOR DEPRESSION: RESULTS FROM THE CAN-BIND-1 COHORT (2019) (0)
- a new strategy to explore gene-environment interactions Epigenetic traces of childhood maltreatment in peripheral blood : (2013) (0)
- EFFECTS OF CYP2C19, CYP2D6, AND ABCB1 GENE VARIANTS ON ESCITALOPRAM AND ARIPIPRAZOLE TREATMENT-RELATED SEXUAL SIDE EFFECTS: RESULTS FROM THE CAN-BIND-1 STUDY (2022) (0)
- AS13-02 - Classification Across the Life Course: Recommendations of the icd Working Group on Mental and Behavioural Disorders in Children and Adolescents (2012) (0)
- P.4.002 Genetic differences in drug-metabolising enzymes: can they be used to predict antidepressant treatment response? (2013) (0)
- Alterations in the Neural Correlates of Affective Inhibitory Control Following Cognitive Behavioral Therapy for Depression: A Canadian Biomarker Integration Network for Depression (CAN-BIND) Study (2022) (0)
- Review of an innovative approach to practical public and clinical health trialsClare Relton (2015) (0)
- Genetic predictors of antidepressant side effects (2012) (0)
- Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder (2018) (0)
- Genome-Based Therapeutic Drugs for Depression ( GENDEP ) study Genetic predictors of antidepressant side effects : A grouped candidate gene approach in the (2014) (0)
- Title Estimating the heritability of reporting stressful life eventscaptured by common genetic variants (2013) (0)
- Candidate genes expression profile associated with antidepressants response: differentiating between baseline "predictors" and longitudinal "targets" (2012) (0)
- 136-THE NEURAL CORRELATES OF EATING DISORDERS: AN FMRI PERSPECTIVE (2004) (0)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (0)
- Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders (2022) (0)
- University of Groningen Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress (2011) (0)
- Faculty Opinions recommendation of Postremission predictors of relapse in women with eating disorders. (2005) (0)
- Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP (2019) (0)
- Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A CAN-BIND Study. (2022) (0)
- Faculty Opinions recommendation of How suicidal bipolar patients are depends on how suicidal ideation is defined. (2009) (0)
- P299. Intranasal Esketamine Versus Intravenous Ketamine: An Observational Study Comparing the Efficacy and Tolerability of Two Novel 'Standard of Care' Treatments for Treatment Resistant Depression (2022) (0)
- P.2.d.022 Gene by drug interactions in genome-wide pharmacogenetic data: a NEWMEDS study (2011) (0)
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture ofmajor depressive disorder (2018) (0)
- The association between genetically determined ABO blood types and major depressive disorder (2021) (0)
- T233. Obesity and Brain Age in First Episode of Schizophrenia-Spectrum Disorders – Effects of Antipsychotic Medications (2018) (0)
- Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with (2019) (0)
- Exploring the role of drug-metabolising enzymes in antidepressant side effects (2015) (0)
- P.1.a.025 New insights into the pharmacogenomics of antidepressant response from the GENDEP and STARD* studies: results of high-density imputation (2016) (0)
- Diagnoses (1991) (0)
- Rudolf Uher - sochy : Rudolf Uher - sculptures. (1998) (0)
- P.1.a.009 Meta-analysis of CYP2C19 association with efficacy and side effects of citalopram and escitalopram (2017) (0)
- The role of bipolar polygenic risk score in the familial transmission of bipolar disorder—An updated analysis (2022) (0)
- Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables (2018) (0)
- The role of loss, danger and humiliation life events in bipolar disorder (2011) (0)
- T45TRANSDIAGNOSTIC FAMILY HISTORY OF MENTAL ILLNESS, POLYGENIC RISK AND DEVELOPMENTAL PSYCHOPATHOLOGY LEADING TO SEVERE MENTAL ILLNESS (2019) (0)
- 26.4 EARLY TRANSDIAGNOSTIC IDENTIFICATION OF RISK FOR MAJOR MOOD AND PSYCHOTIC DISORDERS (2020) (0)
- The brain and eating disorders (2003) (0)
- 4. Brain Default Mode Network Connectivity and Familial Risk of Major Mood Disorders (2023) (0)
- P252. Passive Behavior Sensing Features and Depression Characteristics in a Prospective Relapse Monitoring Study (2022) (0)
- Polygenic Risk Score and Individual Risk Prediction of Bipolar Disorder (2023) (0)
- M38 GENOME-WIDE ASSOCIATION STUDY OF ANHEDONIA IN GENDEP USING A LINEAR MIXED MODEL IDENTIFIES CANDIDATES WITH RELEVANT BIOLOGICAL FUNCTION (2019) (0)
- Title Genomewide association scan of suicidal thoughts andbehaviour in major depression (2011) (0)
- WITHDRAWN: What do we understand about the brain mechanisms underpinning the eating disorders (2006) (0)
- Faculty Opinions recommendation of Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. (2009) (0)
- P.3.002 Informative dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder (2012) (0)
- Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN-BIND 1 report. (2021) (0)
- F82THE RELATIVE IMPACT OF GENETIC SENSITIVITY TO THE ENVIRONMENT AND EXPOSURE TO ENVIRONMENTAL ADVERSITY ON CORTICAL STRUCTURE IN YOUTH (2019) (0)
- 5-HT 2 C GENE VARIANTS AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN : NEW FINDINGS IN AN EVER PRESENT CANDIDATE (2011) (0)
- Faculty Opinions recommendation of How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. (2010) (0)
- P.4.009 Genetic predictors of antidepressant response integrating baseline severity information (2012) (0)
- Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns (2019) (0)
- S0033291721001951jra 559..566 (2023) (0)
- Darrel A. Regier, William E. Narrow, Emily A. Kuhl and David J. Kupfer (eds): The Conceptual Evolution of DSM-5 (2011) (0)
- M83 GENETIC DETERMINANTS OF WEIGHT CHANGE DURING ANTIDEPRESSANT TREATMENT WITH SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS: GENOME-WIDE STUDY AND META-ANALYSIS (2019) (0)
- A genome-wide avenue towards prediction of individual responses to antidepressant and antipsychotic drugs (2010) (0)
- T20 New Insights Into The Pharmacogenomics Of Antidepressant Response From The Gendep And Star*D Studies: Results Of Rare Variant Analysis And High-Density Imputation (2017) (0)
- 2nd TwiCs symposium summary (2017) (0)
- SA105A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES (2019) (0)
- The global impact of anxiety disorders. (2023) (0)
- Diagnoses: Value and Limitations (2020) (0)
- ' s response to reviews Title : Interaction between stress and the BDNF Val 66 Met polymorphism in depression : a systematic review and meta-analysis (2013) (0)
- Novel polygenic risk score links depression-related cortical transcriptomic changes to brain morphology and depressive symptoms in men (2021) (0)
- Augmenting Mental Health Support for Patients Accessing Different Degrees of Formal Psychiatric Care through a Supportive Text Messaging Program: Protocol for a Randomized Controlled Trial (2023) (0)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (0)
- Correction (1960) (0)
- 255. Greater Gyrification of the Inferior Frontal Gyrus as a Marker of Genetic Risk for Bipolar Disorders (2017) (0)
- CS03-02 - the Role of (epi)genetics in Personalizing Psychiatry (2012) (0)
- Are children of depressed mothers exposed to higher contextual, family and mother-based risks? (2011) (0)
- Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (0)
- disorder and other neurodevelopmental disorders in offspring of parents with depression and bipolar disorder (2021) (0)
- Developmental Phenotypes of Sequential Comorbidity Leading to Major Mood Disorders (2023) (0)
- F52. WHO CO-PARENT CHILDREN WITH MOTHERS AND FATHERS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER? CHARACTERIZING INDIVIDUALS WHO HAVE CHILDREN TOGETHER WITH INDIVIDUALS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER (2019) (0)
- Pre-Treatment Resting-State Functional Connectivity Related to Anhedonia and Anxiety are Associated With Antidepressant Response to Escitalopram and Adjunct Aripiprazole (2020) (0)
- Neural markers of familial risk for depression – A systematic review (2022) (0)
- P.3.16 Characterisation of response to antidepressants in a pharmacogenetic trial (2008) (0)
- P.1.034 Copy number variants in CYP450 psychotropic drug metabolising enzymes in a large study of recurrent depressive disorder (2011) (0)
- Identification of common genetic risk variants for autism spectrum disorder (2019) (0)
- Genetic and Epigenetic Models (2018) (0)
- Treatment response in individuals with depression and a history of childhood maltreatment. (2023) (0)
- Transmission of intelligence, working memory, and processing speed from parents to their seven-year-old offspring is function specific in families with schizophrenia or bipolar disorder (2022) (0)
- Dr Uher and Colleagues Reply. (2020) (0)
- P283. Developmental Trajectory of Body Weight in Offspring of Parents With Major Mood Disorders (2022) (0)
- P.4.015 Gene expression profile associated with major depression and with antidepressant response (2012) (0)
- T75GWAS AND PATHWAY ENRICHMENT ANALYSIS IN ADVERSE DRUG REACTIONS IN DEPRESSION (2019) (0)
- P277. Sleep in Children at High Familial Risk for Major Mood Disorders (2022) (0)
- Early Identification of Risk for Major Depressive Disorder in the FORBOW Project (2020) (0)
- P.1.024 Depressive disorder moderates the effect of fat mass and obesity-associated gene (FTO) on body mass index (BMI) (2010) (0)
- Screening young people for obsessive ^ compulsive Screening young people for obsessive ^ compulsive disorder (2006) (0)
- Prospective Association between Childhood Behavioral Inhibition and Anxiety: a Meta-Analysis (2019) (0)
- Therapygenetics: predicting response to CBT in child anxiety from specific genetic markers (2012) (0)
- Genome-wide association summary statistics of antidepressant treatment resistance meta-analysis (2020) (0)
- Genome wide association scan of co-morbid anxiety in major depressive disorder (MDD) [Abstract] (2010) (0)
- P.3.13 Temperament and character of subjects with treatment increase suicidal ideations in the GENDEP study (2009) (0)
- S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort (2019) (0)
- Diagnoses (1996) (0)
- TITLE: Novel polygenic risk score links depression-related cortical transcriptomic changes to brain morphology and symptom severity (2021) (0)
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression (2018) (0)
- SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants (2023) (0)
- 286. Genetic Polymorphism of Brain-Derived Neurotrophic Factor is Related to Antidepressant Efficacy and Treatment-Induced Hippocampal Plasticity in Patients With Major Depressive Disorder: CAN-BIND-1 Study (2023) (0)
- S.10.04 The brain and eating disorders (2003) (0)
- SU95TRANSDIAGNOSTIC FAMILY HISTORY OF MENTAL ILLNESS, EXPOSURE TO ENVIRONMENTAL ADVERSITY, AND PSYCHOPATHOLOGY IN YOUTH (2019) (0)
- University of Birmingham Familiality and SNP heritability of age at onset and episodicity in major depressive disorder (2015) (0)
- General Discussion (1962) (0)
- Faculty Opinions recommendation of Neural substrate of body size: illusory feeling of shrinking of the waist. (2005) (0)
- Active behaviors and screen time in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia (2020) (0)
- Rating Short-Term Psychodynamic Therapy for the Canadian Network for Mood and Anxiety Treatments Depression Guidelines (2017) (0)
This paper list is powered by the following services:
Other Resources About Rudolf Uher
What Schools Are Affiliated With Rudolf Uher?
Rudolf Uher is affiliated with the following schools:
